ABSTRACT
INTRODUCTION
Epilepsy is a chronic disorder characterized by unprovoked, recurring seizures that disrupt the nervous system and can cause mental and physical dysfunction. It affects all age groups. The incidence is highest in children with another but lesser peak occurring after the age of 60 years (1, 2) . Approximately 10-30% of patients with epilepsy continue to have seizures despite medical treatment. Seizures are thought to be the result of an imbalance of neurochemicals and are associated with the production of free radicals which can damage brain cells (3,4) . The brain is especially vulnerable to oxyradical injury due to its high oxygen consumption rate, its abundant lipid content, and the relative paucity of antioxidant enzymes compared with other tissues (5) . The antioxidant enzymes CuZn-superoxide dismutase (SOD), Mn-SOD and glutathione peroxidase are present in intermediate amounts, and the catalase activity is very low. Thus, the glial and neuronal cells may be prone to oxidative stress which has been implicated as a contributory factor in various neurological disorders (6) . It is widely accepted that trace elements play an important role in various metabolic processes, and zinc (Zn), copper (Cu) and selenium (Se) are known to be necessary for the activity of some enzymes. Although many authors have demonstrated an association between some trace elements and epilepsy, the relation has never been convincingly documented, because the data in the literature are conflicting. Moreover, little is known about the changes in trace elements induced by antiepileptic drugs (AEDs) (7) . Melatonin, a neuromodulator produced by the pineal gland, has been shown to have antiepileptic activities in animal studies using several seizure models (8) as well as in cases of childhood epilepsy (9) (4) . The aim of the present study was to evaluate the oxidant/antioxidant status in patients with epilepsy as represented by the levels of malondialdehyde (MDA: as a marker of lipid peroxidation), the antioxidants melatonin and superoxide dismutase, and the trace elements copper and zinc in erythrocyte and serum samples of patients with epilepsy. In addition, the effect of therapy with the antiepileptic drug valproic acid on the oxidant/antioxidant status was, also, evaluated.
Melatonin (as a neuromodulator, not only an antioxidant) will be correlated to the other parameters studied.
SUBJECTS & METHODS
The study included 40 epileptic patients with generalized tonic-clonic seizures, chosen from the Neurology Clinic in Abu El Reish Pediatric Hospital, Cairo University. Their ages ranged between 3 and 12 years, and there were 18 males and 22 females. The 40 patients included: (I) 20 newly diagnosed epileptic children prior to the administration of any form of antiepileptic drug (AED), their mean age + S.D. was 6.6 + 3.9 years, and (II) 20 epileptic children on treatment with the AED Valproic acid for a minimum period of one year. Their mean age + S.D. was 7.4 + 3.2 years. All patients were in the interictal period, or at least 12 hrs. seizure free from sampling time. Excluded from the study were children suffering from progressive brain disease or chronic medical or surgical illness or those receiving chronic medication other than the AED valproic acid. Fifteen normal healthy children (age and sex matched) served as a control group. Their mean age + S.D. was 7.6 + 3.1 years. Detailed information on the study was given to each patient or subject and their accompanying relative, and a written consent to participate in the study was obtained.
All patients were subjected to full clinical examination and electroencephalographic study. The children were under normal daily light-dark cycles. From each case 10 ml venous blood was collected at about 10 p.m. Light remained dim during that nocturnal sampling. The blood sample was divided into two parts: one part was allowed to clot at room temperature and centrifuged at 5000 rpm for 10 min and the serum was collected, and aliquots of that serum were kept frozen at -70°C. The second part of the blood sample was collected in a tube containing heparin, centrifuged, and the retrieved erythrocytes were washed thrice with cold physiological saline and lysed with double distilled water prior to analysis for hemoglobin and SOD estimation.
All 
RESULTS
The results of the present study are shown in table (1) and figures (1-5).
The mean levels ± S.D. of both serum melatonin and MDA showed a significant increase while that of erythrocytic SOD showed a significant decrease in untreated epileptics versus controls. The melatonin mean level then showed a significant decrease in the epileptic patients receiving treatment with VPA as compared to the untreated epileptic group. However, that decreased melatonin level was still significantly higher than that of the control group. Meanwhile, the mean level of MDA further significantly increased while the SOD mean levels further significantly decreased in the epileptic patients treated with VPA compared to both controls and untreated epileptics.
The mean serum zinc level was significantly lower while the mean serum copper was significantly higher in the treated epileptics versus both controls and untreated epileptics.
Significant negative correlation was detected between melatonin and MDA (r = -0.65), while a significant positive correlation was detected between melatonin and SOD (r = 0.52). Negative correlations were detected between MDA and each of SOD (r = -0.59) and zinc (r =-0.53). Meanwhile, MDA was positively correlated with copper (r = 0.61). Also, other negative correlations were detected between serum zinc and copper levels (r= -0.58) and between melatonin and copper (r = -0.43). Table ( 
DISCUSSION
Evidence has accumulated about the involvement of reactive oxygen species (ROS) in epilepsy (19) . MDA levels showed significant increase in the untreated children compared to the MDA levels in the controls. MDA levels showed further significant increase in the treated patients receiving the antiepileptic drug (AED) valproic acid (VPA) indicating that the metabolism of VPA may trigger oxygen dependent tissue injury and elevate free radicals in the body (4, 20) . These free radicals cause a cascade of neurochemical events leading to neurodegeneration and cell death . Moreover, VPA enhances the clearance of selenium and zinc, subsequently leading to decreased synthesis of free radical scavenging enzymes (23, 12) . The present results showed a significant increase in the mean serum levels of melatonin in both untreated and treated epileptic children compared to controls; however, the levels in the treated children were significantly lower than the levels in the untreated children. In addition, melatonin was negatively correlated to MDA and Cu 2+ .
Zn μg/dL
Cu μg/dL (32) , and also, production of ROS and disruption of metabolic enzymatic activity, ultimately leading to activation of apoptotic and/or necrotic processes leading to acute neuronal injury (33) . In the present study, serum Zn 2+ levels showed a non-significant decrease in the untreated epileptic group, while there was a significant decrease in the serum Zn 2+ level in the epileptic children receiving the VPA therapy. This could be attributed to the fact that VPA binds Zn
2+
, thus protecting glutamic acid decarboxylase from the inhibitory effect of Zn 2+ and hence increasing the level of GABA (34) . In accordance with the present results, Lerman-Sagie et al., (35) reported reduced erythrocyte Zn 2+ content in their epileptics. Kuzuya et al. (36) reported lower levels of Zn 2+ in patients who were treated with the AED VPA. In the prospective study done by Altunbasak et al. (37) , the serum and hair levels of Zn 2+ were found to be higher in untreated epileptic patients than those treated with VPA and controls. reported that VPA did not affect Cu
or Zn 2 serum concentrations. In conclusion, it seems possible that oxidant stress is associated with epilepsy and is aggravated with VPA therapy leading to relative reduction in melatonin and absolute reduction in erythroctic SOD and serum zinc concentration respectively. Thus, using melatonin and zinc (in view of their antioxidant activity) as an adjuvant therapy with VPA seems beneficial and needs thorough investigation.
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